Akebia Therapeutics
AKBA
Akebia Therapeutics (AKBA) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 | Aug 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Jul 1, 2026 |
| BTIG | Maintained | Buy | $4.00 | Apr 7, 2026 |
| BTIG | Maintained | Buy | $4.00 from $5.00 | Feb 25, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Feb 6, 2026 |
| Piper Sandler | Maintained | Overweight | $4.00 from $6.00 | Feb 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 | Dec 2, 2025 |
| BTIG | Maintained | Buy | $5.00 | Dec 2, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $8.00 | Oct 30, 2025 |
| BTIG | Maintained | Buy | $5.00 from $10.00 | Oct 29, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $8.00 | Jun 4, 2025 |
| Leerink Partners | Initiated Coverage | Outperform | $7.00 | Apr 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.50 | Apr 4, 2025 |
| Jefferies | Initiated Coverage | Buy | $6.00 | Apr 1, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.50 | Mar 14, 2025 |
| Piper Sandler | Maintained | Overweight | $6.00 from $4.00 | Mar 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.50 | Jan 23, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.50 | Jan 14, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.50 | Oct 23, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $7.50 | Oct 10, 2024 |
Frequently asked questions
What is the latest analyst rating on AKBA?
On Aug 7, 2026, Leerink Partners downgraded Akebia Therapeutics to Market Perform with a price target of $1.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.